chartexchange

EMMA
EMMAUS LIFE SCIENCES INC
stockOTC

EODNov 20, 2026
0.032USD-8.571%(-0.003)14,000
Loading…
Loading…
Healthcare
Biotechnology
HQ
Torrance, CA, USA
Previous Close
$0.04
Beta
0.76
52-Week High
$0.09 2026-08-31
52-Week Low
$0.01 2026-04-28
SMA 50
$0.05
SMA 200
$0.02
Avg. Vol 10D
61,656
Avg. Vol 30D
33,492
Avg. Vol 90D
118,396
Relative Vol
0.42
36.85M
4,583
Jul 18, 2019 · 1-for-6 (reverse)
EMMA Profile

emmaus life sciences, inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan disease. we are initially focusing our product development efforts in sickle cell disease, a genetic disorder. our lead product candidate is an oral pharmaceutical grade l-glutamine treatment that demonstrated positive clinical results in our completed phase 3 clinical trial for sickle cell anemia and sickle ß0-thalassemia.

EMMA Performance
PeriodPriceDateChangeBeta
1W0.022026-11-13+39.13%2.642
1M0.062026-10-22-44.41%-1.498
3M0.032026-08-21-0.31%0.206
6M0.012026-05-21+229.90%0.300
1Y0.012025-11-21+236.84%0.760
2Y0.032024-11-22+18.08%—
5Y1.382021-11-22-97.68%1.651
EMMA Stock Summary

EMMAUS LIFE SCIENCES INC (OTC:EMMA) stock price today is $0.03, and today's volume is 14,000. EMMA is down 8.571% today. The 30 day average volume is 33,492. EMMA market cap is $2.04M with 63.87M shares outstanding.